Vatican Technology Review
SEE OTHER BRANDS

Daily news on science and technology in the Vatican

Vatican Technology Review: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Vatican Technology Review.

Press releases published on July 30, 2025

Clearmind Medicine Files International Patent Application for Novel Combination Therapy Targeting Weight Loss and Fatty Liver Disease

Clearmind Medicine Files International Patent Application for Novel Combination Therapy Targeting Weight Loss and Fatty Liver Disease

Vancouver, Canada, July 30, 2025 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a clinical-stage biotech company focused on discovery and development of novel psychedelic-derived therapeutics to …

happn unveils AI-powered tool to redefine date planning

happn unveils AI-powered tool to redefine date planning

PARIS, July 30, 2025 (GLOBE NEWSWIRE) -- Real-life dating app happn, has launched Perfect Date — a world-first generative AI feature powered by large language models (LLMs). It helps users move from chatting to meeting-up through tailored location …

SciSparc-Clearmind Collaboration Leads to Filing of International Patent Application for Novel Combination Therapy Targeting Weight Loss and Fatty Liver Disease

SciSparc-Clearmind Collaboration Leads to Filing of International Patent Application for Novel Combination Therapy Targeting Weight Loss and Fatty Liver Disease

TEL AVIV, Israel, July 30, 2025 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) ("Company" or "SciSparc"), a specialty clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders and rare diseases of the central …

IMUNON Announces First Patient Dosed in Phase 3 OVATION 3 Study of IMNN-001 in Newly Diagnosed Advanced Ovarian Cancer

IMUNON Announces First Patient Dosed in Phase 3 OVATION 3 Study of IMNN-001 in Newly Diagnosed Advanced Ovarian Cancer

Initiation of additional trial sites and patient enrollment activities ongoing with multiple patients in screening LAWRENCEVILLE, N.J., July 30, 2025 (GLOBE NEWSWIRE) -- IMUNON, Inc. (Nasdaq: IMNN), a clinical-stage company in Phase 3 development of its …

Retab raises $3.5M and launches most powerful document AI platform on the market

Retab raises $3.5M and launches most powerful document AI platform on the market

San Francisco, July 30, 2025 (GLOBE NEWSWIRE) -- AI agents are poised to change the world, but they can't read the documents that run it. Retab, a San Francisco-based startup founded by engineers frustrated by the broken state of document AI, is fixing …

PolyPid to Report Second Quarter 2025 Financial Results and Operational Highlights on August 13, 2025

PolyPid to Report Second Quarter 2025 Financial Results and Operational Highlights on August 13, 2025

PETACH TIKVA, Israel, July 30, 2025 (GLOBE NEWSWIRE) -- PolyPid Ltd. (Nasdaq: PYPD) ("PolyPid" or the "Company"), a late-stage biopharma company aiming to improve surgical outcomes, today announced that it will report its second quarter 2025 financial …

DebitMyData השלימה סבב גיוס ראשוני עם רישום יתר - משיקה התרחבות גלובלית של Human Energy Grid בהיקף של מיליארד דולר

DebitMyData השלימה סבב גיוס ראשוני עם רישום יתר - משיקה התרחבות גלובלית של Human Energy Grid בהיקף של מיליארד דולר

לוגו DebitMyData™ פורט לודרדייל, פלורידה, July 30, 2025 (GLOBE NEWSWIRE) -- DebitMyData™, Inc - העוצמתית סגרה סבב גיוס ראשוני בסכום כפול מהיעד המקורי שלה. גל אמון זה מצד המשקיעים סולל את הדרך לפריסה עולמית נועזת, בהיקף 1 מיליארד דולר, של Human Energy Grid …

Incannex Reports Positive Topline Results from RePOSA Phase 2 Trial of IHL-42X

Incannex Reports Positive Topline Results from RePOSA Phase 2 Trial of IHL-42X

Statistically and clinically significant improvements across key clinical endpoints; IHL-42X reduced AHI by up to 83% from baseline. IHL-42X demonstrates compelling clinical benefit and an outstanding safety profile that exceeded expectations. NEW YORK and …

Shiplify Revolutionizing Revenue Retention Through Accessorial Identification Technology

Shiplify Revolutionizing Revenue Retention Through Accessorial Identification Technology

ATLANTA, July 30, 2025 (GLOBE NEWSWIRE) -- Shiplify, the primary accessorial revenue identifier for carriers, shippers and third-party logistics (3PL) providers, today introduced the first of its kind accessorial ROI calculator. This tool brings …

Cloudbrink Adds Native Identity Management and Crowdstrike Integration to its SASE, Creating a Unified Platform with Higher Security and Less Complexity

Cloudbrink Adds Native Identity Management and Crowdstrike Integration to its SASE, Creating a Unified Platform with Higher Security and Less Complexity

SUNNYVALE, Calif., July 30, 2025 (GLOBE NEWSWIRE) -- Cloudbrink, a leader in high-performance secure connectivity, today introduced a suite of identity management services and an integration with Crowdstrike to its Personal SASE platform. Combined, these …

CPI Aerostructures Receives Follow-on Orders Totaling $2.4 Million for Welded Assemblies

CPI Aerostructures Receives Follow-on Orders Totaling $2.4 Million for Welded Assemblies

EDGEWOOD, N.Y., July 30, 2025 (GLOBE NEWSWIRE) -- CPI Aerostructures, Inc. (“CPI Aero®” or the “Company”) (NYSE American: CVU) today announced that it has received follow-on orders from multiple existing customers totaling $2.4 million to weld complex …

BigCommerce and Feedonomics Deepen Partnership with Google Cloud, Empowering Merchants with Enhanced Discovery, Agentic Search Experiences and AI-Powered Data Enrichment

BigCommerce and Feedonomics Deepen Partnership with Google Cloud, Empowering Merchants with Enhanced Discovery, Agentic Search Experiences and AI-Powered Data Enrichment

AUSTIN, Texas, July 30, 2025 (GLOBE NEWSWIRE) -- BigCommerce (Nasdaq: BIGC), a leading open SaaS ecommerce platform for B2C and B2B businesses, and Feedonomics, a leading data feed management solution, today announced a deepened partnership with Google …

Spectral AI Schedules 2025 Second Quarter Financial Results and Conference Call

Spectral AI Schedules 2025 Second Quarter Financial Results and Conference Call

DALLAS, July 30, 2025 (GLOBE NEWSWIRE) -- Spectral AI (NASDAQ: MDAI) (“Spectral AI” or the “Company”), developer of the AI-driven DeepView® System and focused on medical diagnostics for faster and more accurate treatment decisions in wound care, today …

Immutep Quarterly Activities Report Q4 FY25

Immutep Quarterly Activities Report Q4 FY25

Media Release The pivotal TACTI-004 Phase III trial in first line non-small cell lung cancer (1L NSCLC) continues to build momentum and is recruiting patients at a growing number of activated clinical sites and countries Trial-in-Progress poster for TACTI- …

VYNE Therapeutics Announces Topline Results from Phase 2b Trial with Repibresib Gel in Nonsegmental Vitiligo

VYNE Therapeutics Announces Topline Results from Phase 2b Trial with Repibresib Gel in Nonsegmental Vitiligo

Trial Did Not Meet Primary Endpoint or Key Secondary Endpoint of F-VASI50 and F-VASI75 Nominally Statistically Significant Effects Observed in Key Secondary and Exploratory Endpoints of Change from Baseline in F-VASI and T-VASI at 3% Concentration Company …

Valitor Highlights Three-fold Increase with VLTR-559 in Sustained Potency and Durability over Aflibercept in Preclinical Ocular Wet AMD Models

Valitor Highlights Three-fold Increase with VLTR-559 in Sustained Potency and Durability over Aflibercept in Preclinical Ocular Wet AMD Models

-Data showcased in session titled “Spotlight on Drug Delivery” at the Ophthalmology Innovation Source (OIS) Retina 8th Annual Innovation Summit -VLTR-559, a long-acting anti-VEGF therapy, could reduce dosing frequency for the treatment of wet AMD to twice- …

Nautilus Biotechnology Announces Agreement with the Allen Institute, Further Validating its Approach to Single-Molecule Proteomics

Nautilus Biotechnology Announces Agreement with the Allen Institute, Further Validating its Approach to Single-Molecule Proteomics

• Allen Institute to employ Iterative Mapping, Nautilus’ single-molecule proteomics method, to investigate connection between tau protein and Alzheimer’s disease • Agreement links the organizations’ next-generation proteomics technology and neuroscience …

Profusa Announces Initial $1 Million Bitcoin Investment to Initiate Its Digital Asset Treasury Strategy

Profusa Announces Initial $1 Million Bitcoin Investment to Initiate Its Digital Asset Treasury Strategy

BERKELEY, Calif, July 30, 2025 (GLOBE NEWSWIRE) -- Profusa, Inc. (“Profusa” or the “Company”) (NASDAQ: PFSA), a commercial stage digital health company pioneering the next generation of technology platform enabling the continuous monitoring of an …

ORYZON Reports Financial Results and Corporate Update for Half-Year Ending June 30, 2025

ORYZON Reports Financial Results and Corporate Update for Half-Year Ending June 30, 2025

Between December 2024 and July 2025, Oryzon secured financing totaling €52 M, approx. $61 M (€30.0 M from a capital increase, €7.0 M from commercial bank loans, €13.2 M from the EU-IPCEI grant, and €1.8 M from R…

US Signal Empowers Enterprises with New Infrastructure-as-a-Service Platform Leveraging the Industry Acclaimed InfiniBox™ SSA G4 Storage Solution

US Signal Empowers Enterprises with New Infrastructure-as-a-Service Platform Leveraging the Industry Acclaimed InfiniBox™ SSA G4 Storage Solution

WALTHAM, Mass., July 30, 2025 (GLOBE NEWSWIRE) -- Infinidat, a leading provider of enterprise storage solutions, today announced that US Signal Company, LLC (US Signal), a leading digital infrastructure provider and portfolio company of Igneo …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions